A novel mutation in GCK gene: Beware of SGA child with diabetic mother. (November 2021)
- Record Type:
- Journal Article
- Title:
- A novel mutation in GCK gene: Beware of SGA child with diabetic mother. (November 2021)
- Main Title:
- A novel mutation in GCK gene: Beware of SGA child with diabetic mother
- Authors:
- Tagliaferri, F.
Grosso, C.
Balbo, M.
Bracciolini, G.
Bertelli, E.
Secco, A.
Salina, A.
Aloi, C.
Gallo, M.
Felici, E. - Abstract:
- Abstract: MODY is a monogenic, autosomal dominant form of diabetes mellitus. MODY can be caused by mutations in several genes; glucokinase (GCK) accounts for 30–50% of the cases. The diagnosis can be suspected in early-onset diabetes with atypical features for type 1/type 2. Treatment is usually not recommended. A 5-year-old girl came to our attention for occasional episodes of hyperglycaemia. She was born at term, her birth weight was small for gestational age. At the beginning of her pregnancy, her mother was already on insulin therapy for impaired fasting glucose levels, detected before conception and confirmed in the first weeks of gestation. She was treated with insulin until the childbirth without further investigations. The patient was asymptomatic and in good clinical condition. Basal blood tests have shown a fasting plasma glucose of 125 mg/dl, an HbA1c of 6.5%. Antibodies against islet cells, anti-GAD and anti-ZNT8 antibodies were all negative. A 2-h oral glucose tolerance test was performed and underlined an impaired glucose tolerance. HLA haplotypes were screened, excluding susceptibility. GCK Sanger Sequencing identified a novel heterozygous variant. It is not described as a classical mutations. The analysis has been extended to the parents, finding out the same variant in her mother. To our knowledge this mutation has not been described previously; we believe that this variant is responsible for MODY2 due to FBG and Hb1Ac of all the affected members of family.Abstract: MODY is a monogenic, autosomal dominant form of diabetes mellitus. MODY can be caused by mutations in several genes; glucokinase (GCK) accounts for 30–50% of the cases. The diagnosis can be suspected in early-onset diabetes with atypical features for type 1/type 2. Treatment is usually not recommended. A 5-year-old girl came to our attention for occasional episodes of hyperglycaemia. She was born at term, her birth weight was small for gestational age. At the beginning of her pregnancy, her mother was already on insulin therapy for impaired fasting glucose levels, detected before conception and confirmed in the first weeks of gestation. She was treated with insulin until the childbirth without further investigations. The patient was asymptomatic and in good clinical condition. Basal blood tests have shown a fasting plasma glucose of 125 mg/dl, an HbA1c of 6.5%. Antibodies against islet cells, anti-GAD and anti-ZNT8 antibodies were all negative. A 2-h oral glucose tolerance test was performed and underlined an impaired glucose tolerance. HLA haplotypes were screened, excluding susceptibility. GCK Sanger Sequencing identified a novel heterozygous variant. It is not described as a classical mutations. The analysis has been extended to the parents, finding out the same variant in her mother. To our knowledge this mutation has not been described previously; we believe that this variant is responsible for MODY2 due to FBG and Hb1Ac of all the affected members of family. We suggest high suspicion of an underlying GCK variant in SGA children with hyperglycaemia born to a diabetic mother. … (more)
- Is Part Of:
- Diabetes research and clinical practice. Volume 181(2021)
- Journal:
- Diabetes research and clinical practice
- Issue:
- Volume 181(2021)
- Issue Display:
- Volume 181, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 181
- Issue:
- 2021
- Issue Sort Value:
- 2021-0181-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-11
- Subjects:
- Maturity Onset Diabetes of the Young (MODY) -- Glucokinase (GCK) -- Small for gestational age (SGA)
Diabetes -- Periodicals
Diabetes Mellitus -- Periodicals
616.462 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01688227 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01688227 ↗
http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.diabres.2021.109081 ↗
- Languages:
- English
- ISSNs:
- 0168-8227
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.603700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19855.xml